Summary.-Previous studies have shown that in certain tissues, including colonic carcinomas, cell proliferation may be promoted by serotonin, and indirect evidence suggests that the effects of this amine on colonic tumours involves a cellular-uptake mechanism. In the present study, two specific inhibitors of serotonin uptake, Citalopram and Fluoxetine, are examined for their effects on cell proliferation and tumour growth. Each of the agents was found to suppress cell division in dimethylhydrazine -induced colonic tumours in rats, and to retard the growth of 2 out of 3 lines of human colonic tumours propagated as xenografts in immune-deprived mice.
SEROTONIN is an important stimulant to cell division in many tissues, including both the crypt epithelium of the small intestine (Tutton, 1974) and adenocarcinomas induced by dimethylhydrazine (DMH) in the large intestine of rat (Tutton & Barkla, 1 978a) . Whilst the administration of exogenous serotonin does not accelerate the growth of human colorectal tumours propagated as xenografts in immune-deprived mice, treatment with serotonin-receptor antagonists does retard the growth of such tumours (Tutton & Steel, 1979) . It has been suggested that DMH-induced tumours may have an amine-uptake mechanism (Tutton & Barkla, 1976b) and this suggestion, in relationship to serotonin, can now be tested, since several compounds have been synthesized recently that selectively block the cellular uptake of this amine. Fluoxetine (Lilly 110140, 3 (p-trifluoromethylphenoxy-N-methyl-3-phenyl propylamine) is a potent and highly specific inhibitor of serotonin uptake in central neurones (Fuller & Wong, 1977; Wong et al., 1974) . Fluoxetine has also been shown to inhibit serotonin uptake by, and to promote serotonin efflux from, the isolated small intestine (Gershon & Jonakait, 1979) . Citalopram (Lu 10-171, 1(3-dimethylamino)propyl) -1 -(p -fluorophenyl) -5 -phthalancarbonitril) also specifically inhibits serotonin uptake by a variety of cells (Christensen et al., 1977; Hyttel, 1977 (Bliss., 1967) . Initially, cell proliferation was studied in the jejunal crypts of 18 normal rats and in 5 DMH-induced adenocarcinomas. Cell proliferation was also studied in groups of 6 normal and 6 DMH-treated rats injected i. Table. Immunodeprivation technique. Mice were immunodeprived by a technique similar to that previously reported by Steel et al. (1978) .
Briefly, inice aged 16-20 days were thymectomized under ketamine anaesthesia (Ketlar, 18 Parke-Davis, Sydney. Australia, 0415 mg/kg i.m.). After 18-21 days the mice were injected wvith cytosine arabinoside (Cytosar, Upjohn Co., Michigan) at a dose of 200 mg/kg and were then subjected 48 h later to 8-5 Gy of whole-body irradiation from a 137Cs source (Gamma Cell 1000, Atomic Energy of Canada, Ottawa, Canada). Pretreatment with cytosine arabinoside obviates the need for subsequent reconstitution of marrow that would otherwise be necessary.
Xenograft technique.-Tissues from human colorectal tumours were obtained from surgically resected specimens of large intestine and were rapidly transported to the laboratory in ice-cold Dulbeeco Modified Eagle's Medium (Commonwealth Serum Laboratories, Melbourne, Australia). All subsequent manipulations were carried out under sterile conditions in a Biohazard Cabinet (Clemco, Sydney, Australia). Mice were anaesthetized with Ketamine. Small pieces of tumour (2-3 mm in greatest diameters) were introduced through a single 5mm midline dorsal incision and positioned in lateral s.c. pockets, formed by a blunt dissection, in each flank of the mouse. The dorsal incision was then closed with one 9mm Auto clip (Clay Adams, Parsippany, New Jersey, U.S.A.). After 8-12 weeks, xenografts measuring 2-3 ml were surgically removed from mice and used to propagate the tumour line in a second generation of mice. The procedures used for transplantation into the second and subsequent generation of mice were identical to those for the initial transplantation. In this way particular lines of human colorectal cancer were serially propagated. The tumour lines in the experiment were designated HXM2, HXM3A HXM4. The histopathology of the tumours used in the current experiments ranged from a moderately well-differentiated adenocarcinoma (HXM4) to a poorly differentiated adenocarcinoma (HXM2). The growth of 2 of these lines (HXM2 and HXM4) had previously shown to be inhibited by the serotonin-receptor antagonist BW105C (Barkla & Tutton. 1981 and age, received twice-daily i.p. injections of saline as controls. Each experimental and control group of mice contained 10-13 xenografts. Three further groups of 6 immunodeprived mice, not bearing xenografts, were weighed daily. One of these groups was injected with saline, one with Citalopram (20 mg/kg) and one with Fluoxetine (10 mg/ kg).
Tumour measurement.-Starting on the 24th day after implantation, tumours were measured every 1-2 days for up to 30 days. The greatest and least superficial diameters of xenografts were measured using vernier calipers and the volume of xenografts was calculated as (mean diameter)3 x fl/6. The volume of each tumour on each day of assessment (Vt) was divided by the volume of the same tumour at the start of assessment (Vo) to obtain the relative tumour volume (Vt/Vo), the mean for each group of experimental and control mice plotted as a function of time. Vt/Vo was calculated because interxenograft variations in this parameter arise only during the period of treatment. The statistical significance of apparent differences between the relative volumes of various groups of xenografts at particular times after the start of treatment was assessed by the Mann-Whitney nonparametric test for ranked observations (Sokal & Rohlf, 1969) . rates for jejunal crypt cells and colonic carcinoma cells in rat are shown in the (P < 0.05). However, since these experiments were performed on xenografts of different generations within the same tumour line, precise comparison is not possible. Growth of tumour HXM3 is shown in Fig. 3 . Note that neither Citalopram nor Fluoxetine had any statistically significant effect on this line. The growth of tumour line HXM4 is shown in Fig. 4 (Barkla & Tutton, 1981) . Both Citalopram (Overo, 1978) and Fluoxetine (Masala et al., 1979) have been administered to normal human volunteers without apparent ill-effect, though 1/9 depressed patients treated with Fluoxetine did develop extrapyramidal side effects (Melzer et al., 1979 (Tutton & Barkla, 1976b) . Two pieces of less direct evidence have previously been reported in support of this hypothesis. First, it has been shown that inhibition of monoamine oxidase, a group of enzymes that are responsible only for the degradation of intracellular amines (Neff & Yang, 1974) promotes cell proliferation in colonic tumours but not in the jejunal or colonic crypts (Tutton & Barkla, 1976b) . Secondly, the administration of toxic congeners of serotonin (5,6-and 5,7-dihydroxytryptamine) rapidly produces ultrastructurally observable, cytoplasmic damage in colonic tumour cells, but not in crypt epithelia (Tutton & & Barkla, 1977 , 1978b . The failure of either Citalopram or Fluoxetine to inhibit jejunal-crypt cell division supports the notion that, in these cells, proliferation is stimulated by serotonin acting on a receptor that is located on the plasma membrane and hence does not require an uptake mechanism. In fact, each of these agents actually increases the mitotic activity in jejunal crypts, possibly by interfering with the re-uptake of serotonin into the nearby enterochromaffin cells or serotoninergic nerves from which it was presumably released earlier. Thus there is evidence that in normal intestinal epithelial cells proliferation is stimulated by chemical messengers acting on surfacemembrane receptors, the messenger then being cleared from the region so that the signal to divide is soon terminated. By contrast, in tumours, proliferation appears to be promoted by chemical messengers that are taken into the cytoplasm of the malignant cell, where the messenger may not be subject to the normal clearance mechanisms, and hence the signal may persist, leading to inappropriate cell division and the production of daughter cells each with its own cytoplasmic supply of stimulating messenger substance.
